ranolazine 500 MG
RxNorm concept 616490, clinical drug component (scdc).
- RxCUI
- 616490
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/616490 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 12 HR ranolazine 500 MG Extended Release Oral Tablet (SCD, constitutes)
- 12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa] (SBD, constitutes)
- ranolazine 500 MG Oral Granules (SCD, constitutes)
- ranolazine 500 MG Oral Granules [Aspruzyo] (SBD, constitutes)
- ranolazine (IN, has ingredient)
- ranolazine 500 MG [Ranexa] (SBDC, has tradename)
- ranolazine 500 MG [Aspruzyo] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 616490 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/616490 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 616490. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.